Central Nervous System Cancer
8
4
5
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
12.5%
1 terminated out of 8 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Integrated Cancer Repository for Cancer Research
Short Course Radiotherapy
Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
Niraparib in Tumors Metastatic to the CNS
Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System
CNS Qualitative Interview
Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention
Cyberknife Radiosurgery and Quality of Life